PQA has been busy this year advancing the quality of medication use through measure development and stewardship, education, research and convening. Thank you for your engagement and participation in our work that supports better medication use and high-quality care.
PQA has begun developing a health plan performance measure for chronic obstructive pulmonary disease (COPD). COPD is a high-burden and expensive condition, so ensuring effective, high-quality treatment is a priority for patients and those who care for them.
We are excited to announce that we will be open registration for the 2022 PQA Leadership Summit later this month. This year's summit will take place November 10-11 in Arlington, Va., and explore quality and value in medication use from patient, provider, purchaser, payer and industry perspectives.
Recently published research conducted by the National Pharmaceutical Council, PQA and the University of Rhode Island measured the impact of patient nonadherence to oral anticancer medications. The study findings have been published in the Journal of Managed Care & Specialty Pharmacy.
Each month PQA hosts a Quality Forum Webinar which focuses on best practices and emerging trends in medication use quality, medication services and other initiatives that can improve health care quality.
At PQA, our research develops evidence to support meaningful quality measures, demonstrates the value of medications and pharmacist-provided care, and fosters collaboration within the healthcare system to address social determinants of health (SDOH) and improve medication access.
This past January, PQA published the first edition of the PQA Social Determinants of Health Resource Guide. The guide features 20 real-world SDOH services that are promising for improving the quality and safety of medication use.
Pharmacists and pharmacy teams are an essential part of the health care delivery system. As pharmacies expand patient services, they need tools to demonstrate their value.
In a new Population Health Management article, PQA’s Melissa Castora-Binkley, Lisa Hines and I explain how medication adherence quality measures are relevant and high-impact.
We are less than two weeks away from the 2022 PQA Annual Meeting in Baltimore! I look forward to connecting with you in-person and discussing our shared goals to advance medication use quality.
The early registration dealing for the PQA Annual Meeting is April 4, and we are announcing new details on how to connect with innovators and emerging leaders in medication use quality.
The PQA Annual Meeting is in person, May 3-5, in Baltimore, Md.
We are 10 weeks away from the 2022 PQA Annual Meeting. I am excited to get back together with each of you for our first in-person annual meeting since 2019.
The 2022 PQA Annual Meeting takes place May 3-5 in Baltimore. This will be our first in-person annual meeting in three years. It is our time to reconnect, learn, network and engage in our shared effort to advance healthcare quality.
PQA members are currently voting on three measures up for endorsement and two up for retirement.
PQA offers a variety of student and post-graduate programs, including experiential rotations, internships and fellowships. Each is focused on providing healthcare quality experience to diverse individuals from diverse disciplines.
The fourth quarter every year is a busy time in PQA's measure development work. We're often nearing completion of new measures and planning for the next year, which includes creating or renewing development panels and finalizing the next edition of the PQA Measure Manual
Collaboration is one of PQA's greatest attributes, and our measure development process is a prime example of how our diverse member organizations reach consensus on evaluating medication use quality.
